tiprankstipranks

Frank Yocca Insider Profile

11 Followers
Frank Yocca, CSO at Bioxcel Therapeutics, holds 28.28K shares in Bioxcel Therapeutics (Ticker: BTAI).
tipranks
Frank Yocca

Frank Yocca
Bioxcel Therapeutics (BTAI)
CSO

Ranked #3,973 out of 99,335 Corporate Insiders

Profitable Transactions

100%
4 out of 4 Profitable Transactions

Average Return

+107.60%
Average return per transaction
Time Frame
1 Year
Compare to
No Benchmark

Insider Holdings

$17K
100.00%
A breakdown of Frank Yocca's holdings

Insider Roles

Bioxcel Therapeutics
(BTAI)
CSO
Roles that Frank Yocca holds in companies

Most Profitable Insider Trade

Stock:
Bioxcel Therapeutics
(BTAI)
Rating:Informative Buy
Date:Aug 14, 2019 - Aug 14, 2020
Return:+342.90%
The most profitable trade made by Frank Yocca

Frank Yocca's Trading History

Company Name
Last Transaction Date
Insider Position
Last Transaction
Last Transaction Amount
Holding Value
Bioxcel Therapeutics
Oct 03, 2024
CSO
Uninformative Buy
$17.02K
Success Rate for
BTAI
4 out of 4 profitable transactions on
BTAI
100%
Average Return for
BTAI
Average return per transaction on
BTAI
+107.68%
Date
Transaction
Amount
No. of Shares
Price per Share
Profit
Link to Report
Nov 30, 2018
Informative Buy
$2.34K
-
$5.19
+28.70%
Dec 06, 2018
Informative Buy
$4.68K
-
$5.20
+30.40%
Aug 14, 2019
Informative Buy
$56.76K
-
$8.67
+342.90%
Feb 19, 2020
Uninformative Buy
$32.80K
-
$0.41
Jan 27, 2021
Uninformative Buy
$6.15K
-
$0.41
List of latest transactions for each holding click on a transaction to see Frank Yocca's performance on stock

Frank Yocca insider profile FAQ

What is the percentage of profitable transactions made by Frank Yocca?
The percentage of profitable transactions made by Frank Yocca is 100%.
    What is the average return per transaction made by Frank Yocca?
    The average return per transaction made by Frank Yocca is 107.60%.
      What stocks does Frank Yocca hold?
      Frank Yocca holds: BTAI stocks.
        What was Frank Yocca’s latest transaction?
        Frank Yocca latest transaction was an Uninformative Buy of ―.
          What was Frank Yocca's most profitable transaction?
          Frank Yocca’s most profitable transaction was an Informative Buy of BTAI stock on August 14, 2019. The return on the trade was 342.90%.
            What is Frank Yocca's role in Bioxcel Therapeutics?
            Frank Yocca's role in Bioxcel Therapeutics is CSO.
              How can I follow the stock ratings of top corporate insiders?
              Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.